SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading Update

11 Nov 2025 07:00

RNS Number : 9552G
Forterra plc
11 November 2025
 

11 November 2025

FORTERRA PLC

 

Full year guidance maintained

 

Forterra plc, "the Group" a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the ten-month period ended 31 October 2025.

 

Summary

 

·

YTD revenue of £336m, 16% ahead of the prior year (£290m)

·

New build housing demand remains stronger than the depressed RMI market

·

H2 despatches and revenue expected to be at similar levels to H1

·

Full year guidance maintained; H2 adjusted EBITDA expected to be modestly ahead of the H1 figure

 

Current Trading

 

Tougher prior year comparatives along with a recent moderation of demand from the run rates seen around the middle of the year have resulted in year on year revenue growth over the last four months reducing to 10% relative to the 20.4% reported in H1. New build housing continues to be our strongest market segment with RM&I remaining depressed. Accordingly, we continue to benefit from our greater exposure to extruded or wire cut bricks over soft mud.

 

Department for Business and Trade figures show that domestic brick despatches for the nine-month period to September 2025 were 10% ahead of the 2024 comparative, with our own brick market share continuing to recover toward longer term norms. Brick imports remain subdued, and whilst ahead of the prior year, remain flat as a percentage of overall consumption.

 

We continue to actively manage our production capacity with demand varying significantly by product type. Production continues to ramp up as planned at Desford, with both kilns now operational, increasing our output of extruded bricks and ensuring we continue to meet customer demand following a significant destocking during 2025. Elsewhere, we expect to continue managing output as we retain our discipline in matching production to demand.

 

Our financial position continues to strengthen and we anticipate that year-end net debt before leases will be below H1, with leverage a little above one times adjusted EBITDA on a banking covenant basis.

 

Strategic Progress

 

Construction at our Wilnecote factory is nearing completion, with commissioning underway and the first bricks expected to be produced ahead of the year end. Wilnecote will offer an enhanced range of bricks for the premium commercial and specification market, increasing our exposure to this attractive segment.

 

We have also made good progress in designing and commissioning the initial range of brick slips from our innovative Accrington facility with the initial range due to be launched shortly.

 

The previously announced closures of our Bison Bespoke and Formpave operations have been executed in accordance with our plans.

 

Outlook

 

We anticipate that H2 despatches and revenues will be at similar levels to H1. Consistent with our previous guidance, H2 adjusted EBITDA is expected to be modestly ahead of the H1 figure.

 

Whilst we remain mindful of the continued economic uncertainty and the impact it is having on current demand, the medium-term market fundamentals remain attractive with a shortage of housing, a strong desire within government to address this, and a constrained supply of essential building products. The Board remains confident that our recent investments in new production capacity leave the Group well placed to benefit from a future recovery of our markets.

 

ENQUIRIES

 

Forterra plc +44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

 

FTI Consulting +44 203 727 1340

Richard Mountain / Victoria Hayns

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBCBDBSGBDGUG
Date   Source Headline
20th Jan 20267:00 amRNSEmployee Benefit Trust Share Purchase
7th Jan 20269:39 amRNSEmployee Benefit Trust Share Purchase
2nd Dec 20259:22 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20259:03 amRNSHolding(s) in Company
20th Nov 20259:13 amRNSHolding(s) in Company
18th Nov 20255:03 pmRNSEmployee Benefit Trust Share Purchase
11th Nov 20257:00 amRNSTrading Update
4th Nov 20254:34 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20251:36 pmRNSHolding(s) in Company
23rd Oct 20251:21 pmRNSDirector/PDMR Shareholding
17th Oct 20259:58 amRNSEmployee Benefit Trust Share Purchase
14th Oct 20259:06 amRNSHolding(s) in Company
13th Oct 202510:15 amRNSEmployee Benefit Trust Share Purchase
2nd Oct 20252:54 pmRNSGrant of Options under 2025 SAYE Scheme
11th Aug 20251:15 pmRNSHolding(s) in Company
29th Jul 20257:38 amRNS-RProgressive publishes new research
29th Jul 20257:00 amRNSSix months ended 30 June 2025
23rd Jul 202510:05 amRNSHolding(s) in Company
19th Jun 20257:05 amRNSDirector Declaration
20th May 20251:47 pmRNSAnnual General Meeting 2025 Results
20th May 20257:43 amRNS-RProgressive publishes new research
20th May 20257:00 amRNSAGM Trading Update
13th May 202510:36 amRNSHolding(s) in Company
11th Apr 20259:18 amRNSDirector / PCA Shareholdings
2nd Apr 20252:22 pmRNSDirector/PDMR Shareholding
26th Mar 20255:53 pmRNSAnnual Report & Accounts 2024 & Notice of AGM 2025
25th Mar 20251:47 pmRNSDirector/PDMR Shareholding
20th Mar 20252:44 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSGrant under Performance Share Plan
20th Mar 20257:00 amRNSGrant under Deferred Annual Bonus Plan
18th Mar 20252:23 pmRNSHolding(s) in Company
12th Mar 20258:14 amRNS-RProgressive publishes new research
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSAppointment of Independent Non-Executive Director
27th Feb 20253:35 pmRNSHolding(s) in Company
26th Feb 20252:50 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSDirectorate Change
23rd Jan 20257:00 amRNSFull Year 2024 Trading Update
6th Jan 20259:23 amRNSHolding(s) in Company
2nd Jan 202511:38 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSTrading update to the end of the October
4th Nov 202410:24 amRNSHolding(s) in Company
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company
2nd Oct 20245:35 pmRNSGrant of Options under 2024 SAYE Scheme
11th Sep 20247:00 amRNSDirectorate Change
5th Sep 202411:49 amRNSHolding(s) in Company
2nd Sep 20249:59 amRNSHolding(s) in Company
12th Aug 20243:03 pmRNSHolding(s) in Company
30th Jul 20247:00 amRNSSix months ended 30 June 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.